RACHEL PRINTY: Open Payments
NPI 1104138916 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,051 in 98 payments from 17 companies in 2025. Trend: 2023 $10,504 · 2024 $7,575 · 2025 $10,051
Speaker / faculty: $6,900Food & beverage: $2,983Education: $90Travel & lodging: $78
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 31 | $8,088 |
| UCB, Inc. | 13 | $381 |
| ABBVIE INC. | 9 | $349 |
| GENZYME CORPORATION | 5 | $216 |
| Organon LLC | 14 | $199 |
| Janssen Biotech, Inc. | 5 | $192 |
| LEO Pharma Inc. | 2 | $189 |
| Regeneron Healthcare Solutions, Inc. | 5 | $142 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Botanix SB Inc | 2 | $35 |
Products named: NEMLUVIO, Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, ADBRY, COSENTYX, RINVOQ.
Industry payments across CO — which companies pay providers there.
